Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $5.50 billion. The enterprise value is $5.61 billion.
| Market Cap | 5.50B |
| Enterprise Value | 5.61B |
Important Dates
The next estimated earnings date is Thursday, July 30, 2026, before market open.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Dec 23, 2025 |
Share Statistics
Balchem has 32.13 million shares outstanding. The number of shares has decreased by -0.88% in one year.
| Current Share Class | 32.13M |
| Shares Outstanding | 32.13M |
| Shares Change (YoY) | -0.88% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 91.36% |
| Float | 31.95M |
Valuation Ratios
The trailing PE ratio is 35.16 and the forward PE ratio is 29.50. Balchem's PEG ratio is 3.28.
| PE Ratio | 35.16 |
| Forward PE | 29.50 |
| PS Ratio | 5.20 |
| Forward PS | 4.87 |
| PB Ratio | 4.28 |
| P/TBV Ratio | 17.34 |
| P/FCF Ratio | 31.26 |
| P/OCF Ratio | 24.99 |
| PEG Ratio | 3.28 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.49, with an EV/FCF ratio of 31.90.
| EV / Earnings | 35.51 |
| EV / Sales | 5.31 |
| EV / EBITDA | 21.49 |
| EV / EBIT | 26.19 |
| EV / FCF | 31.90 |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.55 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 1.05 |
| Interest Coverage | 22.54 |
Financial Efficiency
Return on equity (ROE) is 12.68% and return on invested capital (ROIC) is 12.06%.
| Return on Equity (ROE) | 12.68% |
| Return on Assets (ROA) | 8.09% |
| Return on Invested Capital (ROIC) | 12.06% |
| Return on Capital Employed (ROCE) | 13.91% |
| Weighted Average Cost of Capital (WACC) | 8.64% |
| Revenue Per Employee | $782,064 |
| Profits Per Employee | $116,921 |
| Employee Count | 1,352 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 4.62 |
Taxes
In the past 12 months, Balchem has paid $45.54 million in taxes.
| Income Tax | 45.54M |
| Effective Tax Rate | 22.36% |
Stock Price Statistics
The stock price has increased by +8.34% in the last 52 weeks. The beta is 0.83, so Balchem's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +8.34% |
| 50-Day Moving Average | 164.55 |
| 200-Day Moving Average | 161.95 |
| Relative Strength Index (RSI) | 70.05 |
| Average Volume (20 Days) | 263,603 |
Short Selling Information
The latest short interest is 415,630, so 1.29% of the outstanding shares have been sold short.
| Short Interest | 415,630 |
| Short Previous Month | 374,120 |
| Short % of Shares Out | 1.29% |
| Short % of Float | 1.30% |
| Short Ratio (days to cover) | 2.32 |
Income Statement
In the last 12 months, Balchem had revenue of $1.06 billion and earned $158.08 million in profits. Earnings per share was $4.87.
| Revenue | 1.06B |
| Gross Profit | 383.55M |
| Operating Income | 214.34M |
| Pretax Income | 203.61M |
| Net Income | 158.08M |
| EBITDA | 261.22M |
| EBIT | 214.34M |
| Earnings Per Share (EPS) | $4.87 |
Balance Sheet
The company has $72.87 million in cash and $184.71 million in debt, giving a net cash position of -$111.84 million or -$3.48 per share.
| Cash & Cash Equivalents | 72.87M |
| Total Debt | 184.71M |
| Net Cash | -111.84M |
| Net Cash Per Share | -$3.48 |
| Equity (Book Value) | 1.29B |
| Book Value Per Share | 40.00 |
| Working Capital | 236.40M |
Cash Flow
In the last 12 months, operating cash flow was $220.16 million and capital expenditures -$44.18 million, giving a free cash flow of $175.98 million.
| Operating Cash Flow | 220.16M |
| Capital Expenditures | -44.18M |
| Depreciation & Amortization | 46.88M |
| Net Borrowing | -21.20M |
| Free Cash Flow | 175.98M |
| FCF Per Share | $5.48 |
Margins
Gross margin is 36.27%, with operating and profit margins of 20.27% and 14.95%.
| Gross Margin | 36.27% |
| Operating Margin | 20.27% |
| Pretax Margin | 19.26% |
| Profit Margin | 14.95% |
| EBITDA Margin | 24.71% |
| EBIT Margin | 20.27% |
| FCF Margin | 16.64% |
Dividends & Yields
This stock pays an annual dividend of $0.96, which amounts to a dividend yield of 0.56%.
| Dividend Per Share | $0.96 |
| Dividend Yield | 0.56% |
| Dividend Growth (YoY) | 10.34% |
| Years of Dividend Growth | 16 |
| Payout Ratio | 19.71% |
| Buyback Yield | 0.88% |
| Shareholder Yield | 1.45% |
| Earnings Yield | 2.87% |
| FCF Yield | 3.20% |
Analyst Forecast
The average price target for Balchem is $200.75, which is 17.25% higher than the current price. The consensus rating is "Buy".
| Price Target | $200.75 |
| Price Target Difference | 17.25% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 6.16% |
| EPS Growth Forecast (3Y) | 10.67% |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Balchem has an Altman Z-Score of 9.81 and a Piotroski F-Score of 8.
| Altman Z-Score | 9.81 |
| Piotroski F-Score | 8 |